AAAAAA
Results: 1-25/35
Authors:
Porta, M
Citation: M. Porta, Role of organochlorine compounds in the etiology of pancreatic cancer: A proposal to develop methodological standards, EPIDEMIOLOG, 12(2), 2001, pp. 272-276
Authors:
Porta, M
Castan, T
Citation: M. Porta et T. Castan, Development of a tight-binding potential for bcc Zr: Application to the study of vibrational properties - art. no. 134104, PHYS REV B, 6313(13), 2001, pp. 4104
Authors:
Trento, M
Passera, P
Tomalino, M
Bajardi, M
Pomero, F
Allione, A
Vaccari, P
Molinatti, GM
Porta, M
Citation: M. Trento et al., Group visits improve metabolic control in type 2 diabetes - A 2-year follow-up, DIABET CARE, 24(6), 2001, pp. 995-1000
Authors:
Chaturvedi, N
Sjoelie, AK
Porta, M
Aldington, SJ
Fuller, JH
Songini, M
Kohner, EM
Citation: N. Chaturvedi et al., Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study, DIABET CARE, 24(2), 2001, pp. 284-289
Authors:
Porta, M
Ruiz, L
Jariod, M
Carrato, A
Malats, N
Citation: M. Porta et al., Authors' reply: Thinking about interactions and mechanisms, J EPIDEM C, 55(8), 2001, pp. 608-608
Authors:
Segura, JM
Castells, X
Casamitjana, M
Macia, F
Porta, M
Katz, SJ
Citation: Jm. Segura et al., A randomized controlled trial comparing three invitation strategies in a breast cancer screening program, PREV MED, 33(4), 2001, pp. 325-332
Authors:
Porta, M
Gamba, M
Bertacchi, G
Vaj, P
Citation: M. Porta et al., Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders, J NE NE PSY, 70(4), 2001, pp. 538-540
Authors:
Estivill, X
Casals, T
Malats, N
Porta, M
Guarner, L
Real, FX
Citation: X. Estivill et al., Evaluation of the role of CFTR in alcohol related pancreatic disease - Reply, GUT, 49(2), 2001, pp. 312-313
Authors:
Malats, N
Casals, T
Porta, M
Guarner, L
Estivill, X
Real, FX
Citation: N. Malats et al., Cystic fibrosis transmembrane regulator (CFTR) Delta F508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer, GUT, 48(1), 2001, pp. 70-74
Authors:
Stefansson, E
Bek, T
Porta, M
Larsen, N
Kristinsson, JK
Agardh, E
Citation: E. Stefansson et al., Screening and prevention of diabetic blindness, ACT OPHTH S, 78(4), 2000, pp. 374-385
Authors:
Ojajarvi, IA
Partanen, TJ
Ahlbom, A
Boffetta, P
Hakulinen, T
Jourenkova, N
Kauppinen, TP
Kogevinas, M
Porta, M
Vainio, HU
Weiderpass, E
Wesseling, CH
Citation: Ia. Ojajarvi et al., Occupational exposures and pancreatic cancer: a meta-analysis, OCC ENVIR M, 57(5), 2000, pp. 316-324
Authors:
Pomero, F
Allione, A
Min, AM
La Selva, M
Porta, M
Citation: F. Pomero et al., Thiamine, beta-cell function and peripheral glucose utilization in thiamine-responsive megaloblastic anemia (TRMA) syndrome, ACT DIABETO, 37(2), 2000, pp. 103-103
Authors:
Porta, M
Costafreda, S
Malats, N
Guarner, L
Soler, M
Gubern, JM
Garcia-Olivares, E
Andreu, M
Salas, A
Corominas, JM
Alguacil, J
Carrato, A
Rifa, J
Real, FX
Citation: M. Porta et al., Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology, EUR J EPID, 16(6), 2000, pp. 533-541
Authors:
Porta, M
Citation: M. Porta, A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm, PAIN, 85(1-2), 2000, pp. 101-105
Authors:
Alguacil, J
Porta, M
Benavides, FG
Malats, N
Kogevinas, M
Fernandez, E
Carrato, A
Rifa, J
Guarner, L
Citation: J. Alguacil et al., Occupation and pancreatic cancer in Spain: a case-control study based on job titles, INT J EPID, 29(6), 2000, pp. 1004-1013
Authors:
Liesenfeld, B
Kohner, E
Piehlmeier, W
Kluthe, S
Aldington, S
Porta, M
Bek, T
Obermaier, M
Mayer, H
Mann, G
Holle, R
Hepp, KD
Citation: B. Liesenfeld et al., A telemedical approach to the screening of diabetic retinopathy: Digital fundus photography, DIABET CARE, 23(3), 2000, pp. 345-348
Authors:
Porta, M
Malats, N
Alguacil, J
Ruiz, L
Jariod, M
Carrato, A
Rifa, L
Guarner, L
Citation: M. Porta et al., Coffee, pancreatic cancer, and K-ras mutations: updating the research agenda, J EPIDEM C, 54(9), 2000, pp. 656-659
Authors' reply: How is causal inference practised in the biological sciences! (vol 54, pg 559, 2000)
Authors:
Porta, M
Alvarez-Dardet, C
Citation: M. Porta et C. Alvarez-dardet, Authors' reply: How is causal inference practised in the biological sciences! (vol 54, pg 559, 2000), J EPIDEM C, 54(9), 2000, pp. 720-720
Authors:
Porta, M
Alvarez-Dardet, C
Citation: M. Porta et C. Alvarez-dardet, Authors' reply: How is causal interference practised in the biological sciences?, J EPIDEM C, 54(7), 2000, pp. 559-560
Authors:
Mosconi, M
Porta, M
Citation: M. Mosconi et M. Porta, Iteration constructs in data-flow visual programming languages, COMPUT LANG, 26(2-4), 2000, pp. 67-104
Authors:
Karamanos, B
Porta, M
Songini, M
Metelko, Z
Kerenyi, Z
Tamas, G
Rottiers, R
Stevens, LK
Fuller, JH
Citation: B. Karamanos et al., Different risk factors of microangiopathy in patients with Type I diabetesmellitus of short versus long duration. The EURODIAB IDDM Complications Study, DIABETOLOG, 43(3), 2000, pp. 348-355
Authors:
Alguacil, J
Kauppinen, T
Porta, M
Partanen, T
Malats, N
Kogevinas, M
Benavides, FG
Obiols, J
Bernal, F
Rifa, J
Carrato, A
Citation: J. Alguacil et al., Risk of pancreatic cancer and occupational exposures in Spain, ANN OCCUP H, 44(5), 2000, pp. 391-403
Authors:
Angeli, S
Utrera, R
Dib, S
Chissone, E
Naranjo, C
Henriquez, O
Porta, M
Citation: S. Angeli et al., GJB2 gene mutations in childhood deafness, ACT OTO-LAR, 120(2), 2000, pp. 133-136
Authors:
Vineis, P
Malats, N
Porta, M
Real, FX
Citation: P. Vineis et al., Human cancer, carcinogenic exposures and mutation spectra, MUT RES-R M, 436(2), 1999, pp. 185-194
Authors:
Porta, M
Citation: M. Porta, Botulinum toxin type A injections for myofascial pain syndrome and tension-type headache, EUR J NEUR, 6, 1999, pp. S103-S109